MxA is a clinically applicable biomarker for type I interferon activation in systemic lupus erythematosus and systemic sclerosis. (15th March 2019)

Record Type:: Journal Article
Title:: MxA is a clinically applicable biomarker for type I interferon activation in systemic lupus erythematosus and systemic sclerosis. (15th March 2019)
Main Title:: MxA is a clinically applicable biomarker for type I interferon activation in systemic lupus erythematosus and systemic sclerosis
Authors:: Huijser, Erika
van Helden-Meeuwsen, Cornelia G
Groot, Noortje
Bodewes, Iris L A
Wahadat, M Javad
Schreurs, Marco W J
van Daele, Paul L A
Dalm, Virgil A S H
van Laar, Jan A M
van Hagen, P Martin
Waris, Matti
Kamphuis, Sylvia
Versnel, Marjan A
Abstract:
Is Part Of:: Rheumatology. Volume 58:Number 7(2019)
Journal:: Rheumatology
Issue:: Volume 58:Number 7(2019)
Issue Display:: Volume 58, Issue 7 (2019)
Year:: 2019
Volume:: 58
Issue:: 7
Issue Sort Value:: 2019-0058-0007-0000
Page Start:: 1302
Page End:: 1303
Publication Date:: 2019-03-15
Subjects:: Rheumatism -- Periodicals
Rheumatology -- Periodicals
616.723005
Journal URLs:: http://rheumatology.oupjournals.org ↗
http://rheumatology.oxfordjournals.org ↗
http://ukcatalogue.oup.com/ ↗
http://firstsearch.oclc.org ↗
DOI:: 10.1093/rheumatology/kez078 ↗
Languages:: English
ISSNs:: 1462-0324
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library DSC - 7960.731900
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store
Ingest File:: 17311.xml